Company intelligence / Profile preview

Medistik

Ownership: Private
Development stage: Other

Overview

Medistik offers a line of over-the-counter topical analgesics for muscle and joint pain. Their products are widely used in Canada by healthcare professionals, athletes, military health services, and the general public. The formulations are FDA and Health Canada approved and have been on the market since at least 2006. Clinical results are based on user testimonials and professional endorsements rather than formal clinical trial publications; the product has won awards such as Best Joint Health at the National Nutrition Awards.[1][6]

Therapeutic areas: OtherImmunologyRheumatologyNeurology
Modalities: Non-pharmacological therapySmall molecule
Industry: Biotech

Partnerships

Used by Canadian Military Health Servicesdistributed through thousands of clinics/pharmacies across Canada.

Beyond the preview

Go deeper on Medistik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medistik.

Explore the full profile